TEREOTACTIC insertion of electrodes into the brain is an integral part of functional neurosurgery, and ICH is the most feared complication associated with these procedures. Previous reports have demonstrated that hypertension and the use of MER are risk factors for hemorrhage. 10, 12 Neurosurgeons routinely insert intracerebral electrodes to treat movement disorders 13 and provide improved localization in patients with epilepsy. The population of patients receiving stereotactic electrodes is broad, ranging from teenagers with epilepsy to elderly adults with PD. The effect of a patient's comorbidities on the occurrence of ICH has not been well-defined. The CCI 5 is used to predict surgical outcomes in several surgical fields; electrodes during 337 procedures in 259 patients. These procedures included 167 DBSs, 74 RFL of subcortical structures, and 96 depth electrode placements in patients with epilepsy. A retrospective review was performed of the medical records and postoperative cerebral imaging including CT or MR imaging studies. The CCI score for each patient was calculated on the basis of the appropriate weighted Charlson criteria (Table 1) . Patients were classed as hypertensive if the diagnosis was noted in the medical record or if they used antihypertensive medication. (Intraoperative blood pressure is strictly controlled before any electrode insertion.) Similarly, use of anticoagulant medications (such as aspirin, plavix, lovenox, or coumadin) was noted, but these medications were discontinued prior to surgery; preoperative coagulation studies and platelet counts in all patients were within normal limits at the time of surgery. Age, diagnosis, sex, and the use of MER were identified for each patient.
Intracerebral hemorrhages were detected on review of postoperative images and on the independent radiologist's final report. The length of hospitalization and discharge disposition were documented for all patients. Patients with epilepsy who underwent depth electrode implantation were excluded from the length of stay calculations because of prolonged hospitalizations for monitoring intracranial electroencephalography. Patients in the depth electrode group were also excluded in assessments of the differences in hemorrhage rates between DBS and RFL, and in assessments of the difference in length of hospital stays between DBS and RFL patients. Only DBS cases were included when analyzing the risks of MER.
Surgical Procedure
In our stereotactic protocol, the frame is placed on the morning of surgery with the patient in a state of local anesthesia. High-resolution MR images with volumetric magnetization-prepared rapid gradient echo imaging and T2-weighted sequences are obtained and transferred to a Stealth planning station (Medtronic, Inc.). During stereotactic planning of the target coordinates, the patient is returned to the operating room for positioning.
We use a semirecumbent position for patient comfort while elevating the head to minimize cerebrospinal fluid loss. Patients with epilepsy or dystonia typically receive general anesthesia, while patients with movement disorders undergo operations while awake or with light sedation with dexmedetomidine or propofol. Once normal blood pressure is confirmed, the electrodes are stereotactically inserted through precoronal bur holes and anchored after correct placement is confirmed on fluoroscopy. Hippocampal depth electrodes are ordinarily inserted through occipital bur holes. Microelectrode recording is utilized to confirm placement in cases of movement disorders or PD.
Statistical Analysis
Each electrode placed was assigned to a group on the basis of type (DBS, RFL, or depth electrode), patient sex, diagnosis, targeted area, and patient status of hypertension and anticoagulant use. Statistical analysis was performed using commercially available software (JMP, SAS Institute). Differences in the frequency of hemorrhages across groups were evaluated with chi-square tests. Correction for continuity was used if expected frequencies were less than five in 20% of cells. Mean age, CCI score, and length of hospital stay were calculated for each group. Differences between group means were tested with paired t-tests and were considered statistically significant if the probability value was less than 0.05.
Results
A total of 567 electrodes were stereotactically inserted during three types of procedures: DBS to treat movement disorders (219 electrodes), RFL for movement disorders (74 electrodes), and intracerebral depth electrodes for seizure localization (274 electrodes) ( Table 2 ). The mean patient ages were 61, 63, and 30 years in the DBS, RFL, and depth electrode groups, respectively. Fifty-five percent of electrodes were placed in male patients. The mean CCI scores were 0.7, 0.6, and 0.09 for the DBS, RFL, and depth electrode groups, respectively. A diagnosis of hypertension was associated with 81 DBS electrode insertions, 20 RFL electrode procedures, and two depth electrode insertions. In the DBS group, 31 electrodes were placed in patients who had been taking anticoagulant medications 10 days preoperatively, with six patients in the RFL group, and none in the depth electrode group. Electrodes were placed for the treatment of the following conditions: PD (199 electrodes), epilepsy (274), tremor (55), dystonia (37), and pain (two electrodes).
Intracerebral Hemorrhage
There were a total of seven (1.2%) symptomatic hemorrhages in our patients (Table 3 and Fig. 1 ). Hemorrhages were defined as symptomatic if they were detectable on CT or MR imaging and changes were observed on neurological examination. The hemorrhages were associated with targeting the STN in three patients, the globus pallidus internus in two, and the thalamus in one, and the remaining hemorrhage occurred after placement of a hippocampal depth electrode. Only one of these seven hemorrhages occurred in the targeted location; the other six hemorrhages were either subcortical or intraventricular. Four of the hemorrhages were associated with DBS electrodes, two were present after RFL, and one was associated with a hippocampal depth electrode. Of these patients, four (0.9%) had hemorrhages leading to permanent neurological deficits (three in the DBS group and one in the RFL group). There was no significant difference in the rate of hemorrhage between the RFL and DBS groups (p = 0.66).
Risk Factors for Hemorrhage
In the overall group analysis, a history of hypertension was the most significant risk factor associated with hemorrhage (p = 0.007; Table 4 .) Five (8.6%) of the 58 patients with hypertension in the present study experienced symptomatic hemorrhages. This is in contrast with only two (1.0%) of the 201 nonhypertensive patients. Eighteen percent (103/567) of the electrodes were placed in patients who had received a diagnosis of hypertension, and 71% (5/7) of the electrode insertions with symptomatic hemorrhage occurred in patients with a history of hypertension (p = 0.002).
Parkinson disease (p = 0.007) was also significantly associated with hemorrhage, as five of the seven patients with symptomatic hemorrhaging were being treated for PD. Age was also significantly associated with hemorrhage (p = 0.01). The mean age of patients with symptomatic hemorrhage was 65 years, while the mean age of the remaining patients was 41 years. Male sex was also significantly associated with hemorrhage, as all seven patients with hemorrhages were men (p = 0.04). A high CCI score, specific target location, and previous use of anticoagulants were not significantly associated with hemorrhage (p = 0.23, 0.79, and 0.95, respectively).
Because of the inherent differences in the types of comorbidities present in the patients who received depth electrodes compared with the other patient groups, and the possibility for confounding, a separate analysis was performed with the depth electrodes removed to see the effect of CCI score, history of hypertension, age, sex, use of MER, comorbidities, target location, and previous use of anticoagulants on hemorrhage risk. A history of hypertension and diagnosis of PD were predictive of symptomatic hemorrhage (p = 0.03 and 0.001, respectively). Age and sex were no longer predictive of hemorrhage when the depth electrodes were removed from the analysis (p = 0.19 and 0.12, respectively), although all six hemorrhages in the 293 DBS and RFL patients occurred in men. The CCI score, target location, use of MER, and prior use of anticoagulants continued not to be predictive of hemorrhage (p = 0.56, 0.89, 0.34, and 0.99, respectively). Exclusion of the depth electrode group also allowed a comparison of the hemorrhage risk between patients who underwent RFL and those who received DBS. There was no significant difference in hemorrhage rate for patients who received RFL compared with DBS (p = 0.99). There were two hemorrhages after placement of 74 electrodes (2.7%) in the RFL group, and four hemorrhages (1.8%) after placement of 219 electrodes in the DBS group.
Impact of Hemorrhage
As expected, patients with symptomatic hemorrhage had longer hospital stays and were more likely to be discharged to either a rehabilitation center or skilled nursing facility. For these calculations, only the DBS and RFL groups were considered because their surgeries would normally have similar length of stays, while the patients who underwent depth electrode placement had extended hospital stays for seizure localization. There was no significant difference in the length of stay between patients undergoing DBS and RFL (2.9 and 2.6 days, respectively; p = 0.44). Patients with symptomatic hemorrhages had significantly longer hospital stays: 8.2 days compared with 2.7 days (p Ͻ 0.0001). Of the seven patients with symptomatic hemorrhages, three were discharged to a rehabilitation center or skilled nursing facility, three went home, and one died. There was one additional death in this study in a patient without ICH who died of cardiac failure.
Discussion
This study is intended to assess the factors that are significantly associated with ICH during stereotactic electrode procedures. This project is timely as stereotactic techniques are increasingly applied in neurosurgery. Although prior studies have documented the rate of hemorrhage with stereotactic surgery, we sought to comprehensively analyze a broad population of patients of varying ages and diagnoses who have undergone stereotactic insertion of intracerebral electrodes. Our hypothesis was that the rate of hemorrhagic complications is increased in older patients with additional comorbidities, and thus we utilized the CCI in the assessment of hemorrhagic complications.
At the University of Virginia during the study period, the rate of symptomatic hemorrhage after stereotactic surgical procedures for electrode placement was 1.2%. The risk of hemorrhage leading to permanent neurological deficits was 0.7% for the 259 patients who underwent 337 procedures and 567 electrode insertions. Previously published risks of hemorrhage following stereotactic surgery have ranged from 0.6 to 2.1% (Table 5) . 1, 3, 6, 10, 15 In another large series of 481 electrode insertions, Binder et al. 3 reported symptomatic and asymptomatic ICHs. The overall rate of hemorrhage was 3.3%, and only 0.6% were associated with permanent neurological deficits. Lyons and colleagues 15 reported one hemorrhage in a series of 160 procedures involving DBS of the STN, but the neurological outcome in these patients was not reported and potential risk factors were not addressed.
Effect of Hypertension
Hypertension was the most significant risk factor (p = 0.007) predictive of ICH after stereotactic surgery. Previous studies have also documented hypertension as a risk factor for ICH. 3, 10 The patients in our practice are maintained normotensive during the procedure, particularly at the time of intracerebral electrode insertion. The definition of hypertension in our study included patients whose history of hypertension was significant enough to require antihypertensive medications. Five (8.6%) of the 58 patients with hypertension in our series experienced symptomatic hemorrhages. This is in contrast with only two (1.0%) of 201 nonhypertensive patients. Gorgulho and associates 10 reported five hemorrhages after 248 total electrode inser-
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Hemorrhage in stereotaxy 1001 Table  3 ). Images from Patients 1, 2, and 3 were not available from the University of Virginia Department of Radiology archives. tions (2.0%), and hypertension was found to be a significant risk factor (p = 0.011). Hypertension was defined as an intraoperative or postoperative systolic blood pressure 160 mm Hg or higher.
Effect of Age and Parkinson Disease
Consistent with an earlier report, 3 in our subset analysis in which young patients with epilepsy were excluded from the calculation, age was no longer predictive of an increased risk of hemorrhage in adult patients undergoing DBS or RFL. A diagnosis of PD is an important factor, however. In our patients, five of the seven ICHs occurred in parkinsonian patients.
Effect of Comorbidities
In this study we uniquely analyze the effect of comorbidities in patients undergoing stereotactic procedures as related to the development of symptomatic ICH. The CCI is a tool for assessing the risks and outcomes of surgical procedures, and has been used in general, transplant, oncological, and urological surgeries. 4, 5, 8, 9, 16 This scale is weighted toward morbid underlying conditions, and thus we thought it would be a good predictor of hemorrhage in the neurosurgical population. In our series, however, the CCI score was not statistically associated with symptomatic hemorrhage. We do believe that this index may be predictive of nonhemorrhagic complications, and this will be the subject of a future report. There were only two deaths among our patients, and thus the CCI could not be used to predict mortality rates.
Effect of Stereotactic Target
Our initial impression was that target location would correlate with an increased risk of hemorrhage. Of the seven hemorrhages in our series, six occurred while targeting the basal ganglia, and only one occurred at the target itself. There was one hemorrhage in a patient with epilepsy who was undergoing depth electrode insertion to the hippocampus. However, there was no statistically significant correlation between hemorrhage and target location (p = 0.79).
Binder et al. 2 reported higher rates of hemorrhage during DBS procedures targeted to the globus pallidus (6.7%), followed by the STN (2.5%), and there were no hemorrhages in the thalamus. Conversely, Terao and associates 18 reported an increased hemorrhage rate in the thalamus compared with the STN and globus pallidus during RFL procedures. Hemorrhage rates are probably higher in the basal ganglia than in cortical targets. 6 It has been previously suggested that more hemorrhages occur at the target site than along the trajectory, 3 but this was not our experience.
Effect of MER
There has been considerable debate over the use of MERs to provide electrophysiological confirmation of stereotactic targeting. We did not find a significant correlation between hemorrhage and the use of MER; however, there were three hemorrhages in the 86 patients (3.4%) who underwent DBS with MER, compared with one hemorrhage in 133 patients (0.75%) who underwent DBS without MER. The observed risk with MER is more than four times that without MER, but the difference does not reach statistical significance (Yates corrected p = 0.33). We believe the number of hemorrhages in our study population to be insufficient to determine whether the use of MER increases the risk of ICH. An additional study is currently underway to better understand the association.
Gorgulho et al. 10 reported a hemorrhage rate of 2.9% in a MER group compared with 1.4% in a macroelectrode stimulation group, but this difference did not reach statistical significance (p = 0.65). However, Honey et al. 12 reported a significantly increased rate of hemorrhage in their MER group compared with the macroelectrode stimulation group (1.3% compared with 0.2%, p = 0.012). Consideration of the number of MER penetrations is also valid. Binder et al. 3 in 2005 reported a nonsignificant trend toward increased MER penetrations in patients who developed hemorrhages (p = 0.21). An overall review of the literature by Hariz 11 revealed that MER techniques do not necessarily improve targeting accuracy or clinical results compared with techniques using impedance monitoring and macrostimulation, but they are five times more likely to lead to hemorrhagic complications.
Discharge Disposition
The effect of ICH on discharge disposition and length of stay are predictable but important to document. Patients with symptomatic ICHs had longer hospital stays and were less likely to be discharged home.
Conclusions
The use of stereotactic techniques to insert intracerebral electrodes is rapidly expanding as new applications for functional neurosurgery develop. The most feared complication of stereotactic surgery is ICH. In our study with a large cohort of patients with a broad age range and diagnoses, we achieved a symptomatic hemorrhage rate of 1.2%, with only 0.7% of these causing permanent neurological deficits. In only one case did we observe ICH at the level of the stereotactic target. In six patients, the hemorrhages were subcortical along the electrode trajectory or within the ventricular system. Diligent preoperative planning to avoid traversing sulci may thus reduce the risk of subcortical vascular injury.
Consistent with prior studies, we found that hypertension was the most significant risk factor for ICH-hypertensive patients suffered hemorrhagic complications eight times more frequently. Thus, meticulous intraoperative control of blood pressure is recommended, and early preoperative management should be considered before proceeding with surgery. There was also an association with age, male sex, and PD. Surprisingly, comorbidities as assessed with the CCI, the use of MER, the target location, and previous use of anticoagulation medications were not statistically associated with ICH. Hemorrhagic complications were associated with longer hospital stays as patients were less likely to be discharged home. Further studies are underway to determine if the CCI is a useful tool for detecting nonhemorrhagic complications and death.
